Lessons Learned from an Analysis of the Emergency Medical Services' COVID-19 Drive-Through Testing Facilities in Israel

Itay Zmora, Evan Avraham Alpert, Uri Shacham, Nisim Mishraki, Eli Jaffe

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

One strategy for the containment of a pandemic is mass testing. Magen David Adom (MDA), the Israeli National Emergency Medical Services (EMS) Organization undertook this mission by operating a nationwide series of drive-Through testing complexes. The objective of this study is to learn lessons from an analysis of these centers. Data from 198 stationary and mobile drive-Through complexes from March 20, 2020, through October 17, 2020, were analyzed for temporal and geographic factors, and cost. Also, an operational improvement program was implemented and analyzed. A total of 931,074 patients were sampled in the MDA drive-Through system: 46.9% in stationary complexes, and 53.1% in mobile complexes. The optimized cost per patient of home testing was estimated at 74.5 USD compared with 6.55 USD in the drive-Through centers. An operational improvement program lowered the total sampling time from 128 s/patient to 98 s and decreased the total cost per patient from 6.55 USD to 6.27 USD. The EMS led drive-Through complexes were cost-effective and efficient in performing large numbers of viral tests, especially when compared with home testing. Established concepts in clinical operations should be implemented to increase the number of persons that can be tested and decrease cost.

Original languageEnglish
Pages (from-to)2091-2096
Number of pages6
JournalDisaster Medicine and Public Health Preparedness
Volume16
Issue number5
DOIs
StatePublished - 16 Oct 2022

Keywords

  • COVID-19
  • COVID-19 diagnostic testing
  • emergency medical services
  • pandemics

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Fingerprint

Dive into the research topics of 'Lessons Learned from an Analysis of the Emergency Medical Services' COVID-19 Drive-Through Testing Facilities in Israel'. Together they form a unique fingerprint.

Cite this